Chief Technology Officer @ (January 2022 - February 2026)
Chief Operating Officer @ (January 2018 - January 2022)
Vice President @ (January 2016 - January 2018)
Head of External Alliances, Rare Disease Research Unit @ (September 2013 - January 2016)
DPU head - Kiinib DPU @ (January 2012 - September 2013)
Head of Externalised Discovery, Epinova DPU @ (March 2010 - January 2012)
Senior Scientific Analyst, iiVirtual @ (May 2008 - March 2010)
Head Molecular and Cellular Biology @ Biovitrum (May 2005 - May 2008)
Founder Cambridge Biotechnology Ltd @ (May 2001 - May 2005)
Senior Research Scientist @ (September 2000 - May 2001)
Senior Research Scientist @ Parke-Davis (June 1999 - September 2000)
Postdoctoral Research Scientist @ Babraham Institute (April 1994 - June 1999)
PHD Student @ (September 1990 - April 1994)
Michael Skynner Education
Imperial College London
PhD (Biochemistry)
1990-1993
Michael Skynner Skills
Cell Biology
Drug Discovery
Drug Development
Clinical Development
Biotechnology
Lifesciences
Cell
Pharmacology
Molecular Biology
Biochemistry
Life Sciences
Clinical Research
Immunology
Technology Transfer
Analysis
Research
Pharmaceutical Industry
Oncology
Clinical Trials
Project Management
Cell Culture
Business Analysis
Leadership
Michael Skynner Summary
Michael Skynner, is currently a Chief Scientific Officer at Bicycle Therapeutics. Michael Skynner brings experience from previous roles at Bicycle Therapeutics and Pfizer. Michael Skynner holds a 1990 - 1993 PhD in Biochemistry @ Imperial College London. With a robust skill set that includes Cell Biology, Drug Discovery, Drug Development, Clinical Development, Biotechnology and more. Michael Skynner has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Skynner?
Find contact details for 700 million professionals.